Press Releases

Month Year

Month Year

May 27, 2026

Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference

Read more
May 7, 2026

Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update

Read more
May 6, 2026

Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasis
- Photos 2
- Video 3
Read more
May 4, 2026

Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026

Read more
Apr 30, 2026

Insmed to Present at May 2026 Investor Conferences

Read more
Apr 23, 2026

Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026

Read more
Apr 7, 2026

Insmed Provides Clinical Update on Phase 2b CEDAR Study

Read more
Mar 23, 2026

Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease

Read more
Mar 5, 2026

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Feb 19, 2026

Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation